Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003864:Depression, Chemical; D004876:Ergot Alkaloids / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000032:analysis; D006965:Hyperplasia; D007211:Indoles / Q000494:pharmacology*; D008321:Mammary Glands, Animal / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental / Q000209:etiology*; D051379:Mice; D009929:Organ Size; D010902:Pituitary Gland / Q000032:analysis / Q000378:metabolism*; D011230:Precancerous Conditions; D011388:Prolactin / Q000032:analysis / Q000378:metabolism*
D000470:Alkaloids; D004876:Ergot Alkaloids; D007211:Indoles; D011388:Prolactin; D013006:Growth Hormone